Plain-English translation of NCT07230353 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage trial testing a new medication called as a potential treatment for rheumatoid arthritis. The study will give different doses of the medication by injection to about 68 people with moderate to severe rheumatoid arthritis to see how safe it is, how well it's tolerated, and how the body responds to the treatment.
Current rheumatoid arthritis treatments don't work well enough for some patients, or they stop working over time. This trial is exploring whether this new medication could be a better option for people whose arthritis isn't controlled by existing therapies.
You likely qualify if…
You likely don't qualify if…
You will receive injections of the medication under your skin at different dose levels as the trial progresses. Researchers will monitor you closely with blood tests and clinical visits to track how safe the medication is and how your body responds to it. The trial will help doctors understand the right dose and whether this treatment is promising for future use in rheumatoid arthritis.
AI-generated summary from trial data · Aug 18, 2026 · Not medical advice
Georgia
Moldova
New Zealand